Will Spina Bifida Stem-Cell Breakthrough Fuel Medtech?
Inside the operating theater where surgeons stitch spinal tissue before birth, researchers used placenta-derived stem cells in the first in-utero trial. Beyond medical hope, this breakthrough sparks industries: surgical robotics, GMP cell supply chains, and ethical minefields. Founders, clinicians, and futurists: meet the prenatal tech revolution that will reshape healthcare.